Document is current
Any future updates will be listed below
-
Authors
Mancuso, Brooke
Orange, Erica
Eisele, Thomas P.
Ashton, Ruth A.
Littrell, Megan
Matches, Mulenga
Miller, John M.
Chanda, Javan
Assefa, Sosenna
Wagman, Joseph
Silumbe, Kafula
Hamainza, Busiku
Saili, Kochelani
Slutsker, Laurence
Yukich, Joshua
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04800055 at ClinicalTrials.govDocuments that mention this clinical trial
Cost and cost-effectiveness of attractive targeted sugar baits (ATSB) in the context of a phase III cluster randomized control trial in Western Province, Zambia
https://doi.org/10.1186/s12936-025-05716-9
Efficacy of attractive targeted sugar bait stations against malaria in Western Province Zambia: epidemiological findings from a two-arm cluster randomized phase III trial
https://doi.org/10.1186/s12936-024-05175-8
Residual bioefficacy of attractive targeted sugar bait stations targeting malaria vectors during seasonal deployment in Western Province of Zambia
https://doi.org/10.1186/s12936-024-04990-3
Entomological effects of attractive targeted sugar bait station deployment in Western Zambia: vector surveillance findings from a two-arm cluster randomized phase III trial
https://doi.org/10.1186/s12936-024-05045-3
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 28 December 2024
Accepted: 4 December 2025
First Online: 19 December 2025
Declarations
:
: Ethical approval was obtained from the National Health Research Ethics Board (NHREB) at the University Teaching Hospital (ethical institution of record) in Zambia (Ref # 1197–2020), the PATH Research Ethics Committee (Ref # 1460046–5), and the Institutional Review Board at Tulane University (Ref # 2019–595).
: Not applicable.
: The authors declare no competing interests.
